Cargando…

Antibody profile in post-vaccinated & SARS-CoV-2 infected individuals

BACKGROUND & OBJECTIVES: During the COVID-19 pandemic it was important to assess the antibody profile in individuals vaccinated with Covaxin (BBV152) and Covishield (ChAdOx1 nCoV-19) with both 28 and 84 days gaps between two doses, those infected with SARS-CoV-2 and post-COVID-19-infected indivi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patil, Rucha, Shanbhag, Sharda, Shankarkumar, Aruna, Madkaikar, Manisha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807196/ https://www.ncbi.nlm.nih.gov/pubmed/36124500 http://dx.doi.org/10.4103/ijmr.ijmr_3330_21

Ejemplares similares

Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Interpreting the impact of hydroxychloroquine prophylaxis on SARS-CoV-2 infection
por: Yadav, Reetika Malik, et al.
Publicado: (2021)

Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines
por: Wang, Jing, et al.
Publicado: (2023)

Role of anti-human lymphocyte culture cytotoxic antibodies in recurrent spontaneous pregnancy loss women
por: Umapathy, Shankarkumar, et al.
Publicado: (2011)

Correlation of SARS-CoV-2 Neutralization with Antibody Levels in Vaccinated Individuals
por: Chowdhury, Shazeda Haque, et al.
Publicado: (2023)

Individualization of antiretroviral therapy - Pharmacogenomic aspect
por: Dalal, Bhavik, et al.
Publicado: (2015)

Antibody responses induced by Sputnik V vaccine in individuals previously infected with SARS-CoV-2
por: Raiden, Silvina, et al.
Publicado: (2021)

Profile of specific antibodies to the SARS-CoV-2
por: Mou, Danlei, et al.
Publicado: (2021)

Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals
por: Casian, Joseph G., et al.
Publicado: (2021)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals
por: Chen, Elaine C., et al.
Publicado: (2021)

SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals
por: Sano, Kaori, et al.
Publicado: (2022)

Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals
por: Vilibic-Cavlek, Tatjana, et al.
Publicado: (2023)

Third national science symposium on HIV/AIDS: HIV Science 2010
por: Shankarkumar, Aruna, et al.
Publicado: (2011)

Broad and durable antibody response after vaccination with inactivated SARS-CoV-2 in individuals with a history of 2003 SARS-CoV infection
por: Liang, Huang, et al.
Publicado: (2022)

SARS-CoV-2 Vaccine Responses in Individuals with Antibody Deficiency: Findings from the COV-AD Study
por: Shields, Adrian M., et al.
Publicado: (2022)

Post SARS-CoV-2 vaccination effluvium
por: Luu, Ngoc-Nhi C., et al.
Publicado: (2023)

Rapid detection of neutralizing antibodies to SARS-CoV-2 variants in post-vaccination sera
por: Miyakawa, Kei, et al.
Publicado: (2021)

SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays
por: Meyers, Jamie, et al.
Publicado: (2022)

mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals
por: Longet, Stephanie, et al.
Publicado: (2022)

Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders
por: Dinoto, Alessandro, et al.
Publicado: (2022)

Antibody Response to SARS-CoV-2 Infection and Vaccination in COVID-19-naïve and Experienced Individuals
por: Uprichard, Susan L., et al.
Publicado: (2022)

Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals
por: Hayer, Johannes, et al.
Publicado: (2022)

Antibody and T-cellular response to COVID-19 booster vaccine in SARS-CoV-1 survivors
por: Lu, Bi-Nan, et al.
Publicado: (2022)

SARS-CoV-2 vaccine-induced antibody and T cell response in SARS-CoV-1 survivors
por: Duan, Li-Jun, et al.
Publicado: (2022)

Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
por: Robbiani, Davide F., et al.
Publicado: (2020)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 booster vaccines
por: Loving, Hanna S., et al.
Publicado: (2022)

Assessment of Anti-SARS-CoV-2 Antibodies Post-Coronavac Vaccination in the Amazon Region of Brazil
por: Bichara, Carlos David Araújo, et al.
Publicado: (2021)

Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
por: Goto, Takeyuki, et al.
Publicado: (2022)

Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies
por: Aijaz, Javeria, et al.
Publicado: (2023)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Evolution of antibody profiles against SARS-CoV-2 in experienced and naïve vaccinated elderly people
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Microarray Profiling of Vaccination-Induced Antibody Responses to SARS-CoV-2 Variants of Interest and Concern
por: Svetlova, Julia, et al.
Publicado: (2022)

Detection of Antibody Responses against SARS-CoV-2 in Plasma and Saliva from Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Detection of Antibody Responses Against SARS-CoV-2 in Plasma and Saliva From Vaccinated and Infected Individuals
por: Klingler, Jéromine, et al.
Publicado: (2021)

Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
por: Batchi-Bouyou, Armel Landry, et al.
Publicado: (2022)

Reduced antibody response to COVID-19 vaccine composed of inactivated SARS-CoV-2 in diabetic individuals
por: Cheng, Yandong, et al.
Publicado: (2022)

Antibody responses to an inactivated SARS-CoV-2 vaccine in individuals aged from 50 to 102 years
por: Zhu, Hong-Hong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cp3bh0ajuijnbf5i8qbn1um9l1